A Phase I Study of Tesetaxel Administered in Combination With Capecitabine to Subjects With Solid Tumors.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 23 Jul 2012
At a glance
- Drugs Capecitabine; Tesetaxel
- Indications Solid tumours
- Focus Adverse reactions
- 23 Jul 2012 Planned End Date changed from 1 Jul 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 11 Mar 2012 Planned End Date changed from 1 Nov 2011 to 1 Jul 2012 as reported by clinicalTrials.gov.
- 04 Jul 2011 Status changed from recruiting to active, no longer recruiting.